Characterization of 75:25 poly(1-lactide-co-ε-caprolactone) thin films for the endoluminal delivery of adipose-derived stem cells to abdominal aortic aneurysms

Tissue Engineering

Volumn 12, Issue 9, 2006, Pages 2591-2600

  Burks, Chris A ^a,b   Bundy, Kirk ^b   Fotuhi, Parwis ^a   Alt, Eckhard ^a,b,c  

^a Tulane Center for Cardiovascular Health   (United States)

^b Tulane University   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTIC ANEURYSMS; ADIPOSE TISSUE DERIVED STEM CELLS (ADSC); DEGRADATION TIME; ENDOLUMINAL DELIVERY;

CAUSTIC SODA; CELL CULTURE; COMPOSITION; HYDROCHLORIC ACID; MECHANICAL PROPERTIES; SHEAR STRESS; STIFFNESS; STRENGTH OF MATERIALS; TISSUE; YIELD STRESS;

THIN FILMS;

COPOLYMER; ETHYLENE OXIDE; FIBRONECTIN; HYDROCHLORIC ACID; POLY(LACTIDE CO EPSILON CAPROLACTONE); SODIUM HYDROXIDE; UNCLASSIFIED DRUG; BIOMATERIAL; LACTIDE CAPROLACTONE COPOLYMER; LACTIDE-CAPROLACTONE COPOLYMER; POLYESTER;

ABDOMINAL AORTA ANEURYSM; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; AORTA WALL; ARTICLE; BIODEGRADABILITY; BLOOD VESSEL WALL; CELL ADHESION; CONTROLLED STUDY; FILM; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MATERIAL COATING; PRIORITY JOURNAL; REPRODUCIBILITY; SHEAR STRESS; STEM CELL; STEM CELL TRANSPLANTATION; SURFACE PROPERTY; TREATMENT INDICATION; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; MALE; MATERIALS TESTING; METHODOLOGY; MIDDLE AGED; TENSILE STRENGTH; TRANSPLANTATION;

ADIPOSE TISSUE; AORTIC ANEURYSM, ABDOMINAL; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; HUMANS; MALE; MATERIALS TESTING; MIDDLE AGED; POLYESTERS; STEM CELL TRANSPLANTATION; STEM CELLS; TENSILE STRENGTH;

EID: 33750629680     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.2591     Document Type: Article

References (59)

1. Lindholm, L., Ejlertsson, G., Forsberg, L., and Norgren, L. Low prevalence of abdominal aortic aneurysm in hypertensive patients: a population-based study. Acta Med Scand 218, 305, 1985.
2. O'Kelly, T. J., and Heather, B. P. General practice-based population screening for abdominal aortic aneurysms: a pilot study. Br J Surg 76, 479, 1989.
3. Melton, L. J., 3rd, Bickerstaff, L. K., Hollier, L. H., Van Peenen, h. J., Lie, J. T., Pairolero, P. C., Cherry, K. J., and O'Fallon, W. M. Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol 120, 379, 1984.
4. Isselbacher, E. M. Thoracic and abdominal aortic aneurysms. Circulation 111, 816, 2005.
5. Santilli, J. D., and Santilli, S. M. Diagnosis and treatment of abdominal aortic aneurysms. Am Fam Physician 56, 1081, 1997.
6. Al-Omran, M., Verma, S., Lindsay, T. F., Weisel, R. D., and Sternbach, Y. Clinical decision making for endovascular repair of abdominal aortic aneurysm. Circulation 110, e517, 2004.
7. Ichihashi, K. Effects of aging on aortic diameters and distensibility in Marfan's syndrome: comparison with healthy subjects. J Cardiol 35, 19, 2000.
8. Nataatmadja, M., West, M., West, J., Summers, K., Walker, P., Nagata, M., and Watanabe, T. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108 (Suppl 1), II329, 2003.
9. MacSweeney, S. T., Powell, J. T., and Greenhalgh, R. M. Pathogenesis of abdominal aortic aneurysm. Br J Surg 81, 935, 1994.
10. Brady, A. R., Thompson, S. G., Fowkes, F. G., Greenhalgh, R. M., and Powell, J. T. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110, 16, 2004.
11. Krupski, W. C., and Rutherford, R. B. Update on open repair of abdominal aortic aneurysms: the challenges for endovascular repair. J Am Coll Surg 199, 946, 2004.
12. Parodi, J. C., Palmaz, J. C., and Barone, h. D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5, 491, 1991.
13. Rutherford, R. B., and Krupski, W. C. Current status of open versus endovascular stent-graft repair of abdominal aortic aneurysm. J Vasc Surg 39, 1129, 2004.
14. Allaqaband, S., Mortada, M. E., Tumuluri, R., Kumar, A., and Bajwa, T. K. Endovascular stent graft repair of abdominal aortic aneurysms in high-risk patients: a single center experience. J Interv Cardiol 17, 71, 2004.
15. Chaikof, E. L., Lin, P. H., Brinkman, W. T., Dodson, T. F., Weiss, V. J., Lumsden, A. B., Terramani, T. T., Najibi, S., Bush, R. L., Salam, A. A., and Smith, R. B., 3rd. Endovascular repair of abdominal aortic aneurysms: risk stratified outcomes. Ann Surg 235, 833, 2002.
16. Zarins, C. K., Shaver, D. M., Arko, F. R., Schubart, P. J., Lengle, S. J., and Dixon, S. M. Introduction of endovascular aneurysm repair into community practice: initial results with a new Food and Drug Administration-approved device. J Vasc Surg 36, 226, 2002.
17. Prinssen, M., Verhoeven, E. L., Buth, J., Cuypers, P. W., van Sambeek, M. R., Balm, R., Buskens, E., Grobbee, D. E., and Blankensteijn, J. D. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351, 1607, 2004.
18. Yue, X., van der Lei, B., Schakenraad, J. M., van Oene, G. H., Kuit, J. H., Feijen, J., and Wildevuur, C. R. Smooth muscle cell seeding in biodegradable grafts in rats: a new method to enhance the process of arterial wall regeneration. Surgery 103, 206, 1988.
19. Allaire, E., Muscatelli-Groux, B., Guinault, A. M., Pages, C., Goussard, A., Mandet, C., Bruneval, P., Melliere, D., and Becquemin, J. P. Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg 239, 417, 2004.
20. van der Lei, B., Wildevuur, C. R., and Nieuwenhuis, P. Compliance and biodegradation of vascular grafts stimulate the regeneration of elastic laminae in neoarterial tissue: an experimental study in rats. Surgery 99, 45, 1986.
21. Davani, S., Marandin, A., Mersin, N., Royer, B., Kantelip, B., Herve, P., Etievent, J. P., and Kantelip, J. P. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 108 (Suppl 1), II253, 2003.
22. Abedin, M., Tintut, Y., and Demer, L. L. Mesenchymal stem cells and the artery wall. Circ Res 95, 671, 2004.
23. Xu, Q., Zhang, Z., Davison, F., and Hu, Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 93, e76, 2003.
24. Urbich, C., and Dimmeler, S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14, 318, 2004.
25. Griese, D. P., Ehsan, A., Melo, L. G., Kong, D., Zhang, L., Mann, M. J., Pratt, R. E., Mulligan, R. C., and Dzau, V. J. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710, 2003.
26. Tomita, S., Mickle, D. A., Weisel, R. D., Jia, Z. Q., Tumiati, L. C., Allidina, Y., Liu, P., and Li, R. K. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123, 1132, 2002.
27. Wang, J. S., Shum-Tim, D., Galipeau, J., Chedrawy, E., Eliopoulos, N., and Chiu, R. C. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120, 999, 2000.
28. Kobayashi, T., Hamano, K., Li, T. S., Katoh, T., Kobayashi, S., Matsuzaki, M., and Esato, K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 89, 189, 2000.
29. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 697, 1999.
30. Pittenger, M. F., and Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
31. Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., and Shin'oka, T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24, 2303, 2003.
32. Matsumura, G., Miyagawa-Tomita, S., Shin'oka, T., Ikada, Y., and Kurosawa, h. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 108, 1729, 2003.
33. Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, h. P., and Hedrick, M. h. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
34. Lee, R. H., Kim, B., Choi, I., Kim, H., Choi, h. S., Suh, K., Bae, Y. C., and Jung, J. S. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14, 311, 2004.
35. Gimble, J., and Guilak, F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5, 362, 2003.
36. De Ugarte, D. A., Morizono, K., Elbarbary, A., Alfonso, Z., Zuk, P. A., Zhu, M., Dragoo, J. L., Ashjian, P., Thomas, B., Benhaim, P., Chen, I., Fraser, J., and Hedrick, M. h. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174, 101, 2003.
37. Planat-Benard, V., Silvestre, J. S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R., Clergue, M., Manneville, C., Saillan-Barreau, C., Duriez, M., Tedgui, A., Levy, B., Penicaud, L., and Casteilla, L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109, 656, 2004.
38. Hiljanen-Vainio, M. P., Orava, P. A., and Seppala, J. V. Properties of epsilon-caprolactone/DL-lactide (epsilon-CL/ DL-LA) copolymers with a minor epsilon-CL content. J Biomed Mater Res 34, 39, 1997.
39. Tang, Z. G., Black, R. A., Curran, J. M., Hunt, J. A., Rhodes, N. P., and Williams, D. F. Surface properties and biocompatibility of solvent-cast poly[-caprolactone] films. Biomaterials 25, 4741, 2004.
40. Zhu, Y., Gao, C., Liu, X., and Shen, J. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules 3, 1312, 2002.
41. Shuai, X., Wei, M., Porbeni, F. E., Bullions, T. A., and Tonelli, A. E. Formation of and coalescence from the inclusion complex of a biodegradable block copolymer and alpha-cyclodextrin. 2: a novel way to regulate the biodegradation behavior of biodegradable block copolymers. Biomacromolecules 3, 201, 2002.
42. Jeong, S. I., Kim, B. S., Kang, S. W., Kwon, J. H., Lee, Y. M., Kim, S. H., and Kim, Y. h. In vivo biocompatibility and degradation behavior of elastic poly(L-lactide-co-epsilon-caprolactone) scaffolds. Biomaterials 25, 5939, 2004.
43. Xu, C. Y., Inai, R., Kotaki, M., and Ramakrishna, S. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials 25, 877, 2004.
44. Watanabe, M., Shin'oka, T., Tohyama, S., Hibino, N., Konuma, T., Matsumura, G., Kosaka, Y., Ishida, T., Imai, Y., Yamakawa, M., Ikada, Y., and Morita, S. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 7, 429, 2001.
45. MLigiliche, N. L., Tabata, Y., Kitada, M., Endoh, K., Okamato, K., Fujimoto, E., and Ide, C. Poly lactic acid-caprolactone copolymer tube with a denatured skeletal muscle segment inside as a guide for peripheral nerve regeneration: a morphological and electrophysiological evaluation of the regenerated nerves. Anat Sci Int 78, 156, 2003.
46. Barralet, J. E., Wallace, L. L., and Strain, A. J. Tissue engineering of human biliary epithelial cells on polyglycolic acid/polycaprolactone scaffolds maintains long-term phenotypic stability. Tissue Eng 9, 1037, 2003.
47. Lee, S. H., Kim, B. S., Kim, S. H., Choi, S. W., Jeong, S. I., Kwon, I. K., Kang, S. W., Nikolovski, J., Mooney, D. J., Han, Y. K., and Kim, Y. h. Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering. J Biomed Mater Res 66A, 29, 2003.
48. Brostrom, J., Boss, A., and Chronakis, I. S. Biodegradable films of partly branched poly(1-lactide)-co-poly(epsilon-caprolactone) copolymer: modulation of phase morphology, plasticization properties and thermal depolymerization. Biomacromolecules 5, 1124, 2004.
49. Jeong, S. I., Kim, S. H., Kim, Y. H., Jung, Y., Kwon, J. H., Kim, B. S., and Lee, Y. M. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 15, 645, 2004.
50. Tsuji, h. I., Yoshito. Blends of aliphatic polyesters. I. Physical properties and morphologies of solution-cast blends from Poly(D,L-lactide) and poly(ε-caprolactone). Journal of Applied Polymer Science 60, 2367, 1996.
51. Grabow, N., Schlun, M., Sternberg, K., Hakansson, N., Kramer, S., and Schmitz, K. P. Mechanical properties of laser cut poly(L-lactide) micro-specimens: implications for stent design, manufacture, and sterilization. J Biomech Eng 127, 25, 2005.
52. Johnston, K. W., Rutherford, R. B., Tilson, M. D., Shah, D. M., Hollier, L., and Stanley, J. C. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13, 452, 1991.
53. Miller, D. C., Thapa, A., Haberstroh, K. M., and Webster, T. J. Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials 25, 53, 2004.
54. Perego, G., Preda, P., Pasquinelli, G., Curti, T., Freyrie, A., and Cenni, E. Functionalization of poly-L-lactic-co-epsilon-caprolactone: effects of surface modification on endothelial cell proliferation and hemocompatibility. J Biomater Sci Polym Ed 14, 1057, 2003.
55. Birchall, I. E., Field, P. L., and Ketharanathan, V. Adherence of human saphenous vein endothelial cell monolayers to tissue-engineered biomatrix vascular conduits. J Biomed Mater Res 56, 437, 2001.
56. Flemming, R. G., Murphy, C. J., Abrams, G. A., Goodman, S. L., and Nealey, P. F. Effects of synthetic micro- and nanostructured surfaces on cell behavior. Biomaterials 20, 573, 1999.
57. Gao, J., Niklason, L. E., and Langer, R. Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells. J Biomed Mater Res 42, 417, 1998.
58. Faucheaux, N., Schweiss, R., Lutzow, K., Werner, C., and Groth, T. Self-assembled monolayers with different terminating groups as model substrates for cell adhesion studies. Biomaterials 25, 2721, 2004.
59. Poh, M., Boyer, M., Solan, A., Dahl, S. L., Pedrotty, D., Banik, S. S., McKee, J. A., Klinger, R. Y., Counter, C. M., and Niklason, L. E. Blood vessels engineered from human cells. Lancet 365, 2122, 2005.